{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:29:15Z","timestamp":1706747355556},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T00:00:00Z","timestamp":1705881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T00:00:00Z","timestamp":1705881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s00108-023-01655-2","type":"journal-article","created":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T19:02:11Z","timestamp":1705950131000},"page":"93-106","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Management der ANCA-assoziierten Vaskulitiden","Management of ANCA-associated vasculitides"],"prefix":"10.1007","volume":"65","author":[{"given":"Christian","family":"L\u00f6ffler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Hellmich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,22]]},"reference":[{"key":"1655_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2023.1131965","author":"G Bader","year":"2023","unstructured":"Bader\u00a0G, Itan\u00a0M, Edry-Botzer\u00a0L et\u00a0al (2023) Adaptive immune response to BNT162b2 mRNA vaccine in immunocompromised adolescent patients. Front Immunol. https:\/\/doi.org\/10.3389\/FIMMU.2023.1131965","journal-title":"Front Immunol"},{"key":"1655_CR2","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1136\/ARD-2022-222776","volume":"81","author":"A Bettiol","year":"2022","unstructured":"Bettiol\u00a0A, Urban\u00a0ML, Bello\u00a0F et\u00a0al (2022) Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a\u00a0European multicentre observational study. Ann Rheum Dis 81:1769\u20131772. https:\/\/doi.org\/10.1136\/ARD-2022-222776","journal-title":"Ann Rheum Dis"},{"key":"1655_CR3","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/NRRHEUM.2017.140","volume":"13","author":"X Bossuyt","year":"2017","unstructured":"Bossuyt\u00a0X, Cohen Tervaert\u00a0JW, Arimura\u00a0Y et\u00a0al (2017) Position paper: revised 2017 international consensus on testing of ANCas in granulomatosis with polyangiitis and microscopic polyangiitis. Nat Rev Rheumatol 13:683\u2013692. https:\/\/doi.org\/10.1038\/NRRHEUM.2017.140","journal-title":"Nat Rev Rheumatol"},{"key":"1655_CR4","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1093\/RHEUMATOLOGY\/KEX170","volume":"56","author":"X Bossuyt","year":"2017","unstructured":"Bossuyt\u00a0X, Rasmussen\u00a0N, van Paassen\u00a0P et\u00a0al (2017) A multicentre study to improve clinical interpretation of proteinase\u20113 and myeloperoxidase anti-neutrophil cytoplasmic antibodies. Rheumatology 56:1533\u20131541. https:\/\/doi.org\/10.1093\/RHEUMATOLOGY\/KEX170","journal-title":"Rheumatology"},{"key":"1655_CR5","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/ART.41534","volume":"73","author":"A Canzian","year":"2021","unstructured":"Canzian\u00a0A, Venhoff\u00a0N, Urban\u00a0ML et\u00a0al (2021) Use of biologics to treat relapsing and\/or refractory eosinophilic granulomatosis with polyangiitis: data from a\u00a0European collaborative study. Arthritis Rheumatol 73:498\u2013503. https:\/\/doi.org\/10.1002\/ART.41534","journal-title":"Arthritis Rheumatol"},{"key":"1655_CR6","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1136\/ANNRHEUMDIS-2017-212878","volume":"77","author":"P Charles","year":"2018","unstructured":"Charles\u00a0P, Terrier\u00a0B, Perrodeau \u00c9 et\u00a0al (2018) Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a\u00a0multicentre, randomised controlled, phase\u00a0III trial (MAINRITSAN2). Ann Rheum Dis 77:1144\u20131150. https:\/\/doi.org\/10.1136\/ANNRHEUMDIS-2017-212878","journal-title":"Ann Rheum Dis"},{"key":"1655_CR7","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1002\/ACR.24634\/ABSTRACT","volume":"73","author":"SA Chung","year":"2021","unstructured":"Chung\u00a0SA, Langford\u00a0CA, Maz\u00a0M et\u00a0al (2021) 2021 American college of rheumatology\/vasculitis foundation guideline for the management of antineutrophil cytoplasmic antibody\u2013associated vasculitis. Arthritis Care Res 73:1088\u20131105. https:\/\/doi.org\/10.1002\/ACR.24634\/ABSTRACT","journal-title":"Arthritis Care Res"},{"key":"1655_CR8","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1148\/RADIOLOGY.215.3.R00MA07689","volume":"215","author":"P Cluzel","year":"2000","unstructured":"Cluzel\u00a0P, Martinez\u00a0F, Bellin\u00a0MF et\u00a0al (2000) Transjugular versus percutaneous renal biopsy for the diagnosis of parenchymal disease: comparison of sampling effectiveness and complications. Radiology 215:689\u2013693. https:\/\/doi.org\/10.1148\/RADIOLOGY.215.3.R00MA07689","journal-title":"Radiology"},{"key":"1655_CR9","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00393-020-00805-3","volume":"79","author":"E Csernok","year":"2020","unstructured":"Csernok\u00a0E, Hellmich\u00a0B (2020) ANCA-Diagnostik bei Vaskulitiden. Z\u00a0Rheumatol 79:669\u2013678. https:\/\/doi.org\/10.1007\/s00393-020-00805-3","journal-title":"Z Rheumatol"},{"key":"1655_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/J.AUTREV.2020.102514","author":"E Csernok","year":"2020","unstructured":"Csernok\u00a0E, Hellmich\u00a0B (2020) Usefulness of vasculitis biomarkers in the era of the personalized medicine. Autoimmun Rev. https:\/\/doi.org\/10.1016\/J.AUTREV.2020.102514","journal-title":"Autoimmun Rev"},{"key":"1655_CR11","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S0190-9622(94)70224-1","volume":"31","author":"RA DeRemee","year":"1994","unstructured":"DeRemee\u00a0RA, Specks\u00a0U, Daniel Su\u00a0WP (1994) Cutaneous Wegener\u2019s granulomatosis: clinical, histopathologic, and immunopathologic features of thirty patients. J\u00a0Am Acad Dermatol 31:605\u2013612. https:\/\/doi.org\/10.1016\/S0190-9622(94)70224-1","journal-title":"J Am Acad Dermatol"},{"key":"1655_CR12","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/00000478-199006000-00006","volume":"14","author":"KO Devaney","year":"1990","unstructured":"Devaney\u00a0KO, Travis\u00a0WD, Hoffman\u00a0G et\u00a0al (1990) Interpretation of head and neck biopsies in Wegener\u2019s granulomatosis. A\u00a0pathologic study of 126 biopsies in 70\u00a0patients. Am J Surg Pathol 14:555\u2013564. https:\/\/doi.org\/10.1097\/00000478-199006000-00006","journal-title":"Am J Surg Pathol"},{"key":"1655_CR13","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1513\/ANNALSATS.201610-829OC","volume":"14","author":"DM DiBardino","year":"2017","unstructured":"DiBardino\u00a0DM, Haas\u00a0AR, Lanfranco\u00a0AR et\u00a0al (2017) High complication rate after introduction of transbronchial cryobiopsy into clinical practice at an academic medical center. Ann Am Thorac Soc 14:851\u2013857. https:\/\/doi.org\/10.1513\/ANNALSATS.201610-829OC","journal-title":"Ann Am Thorac Soc"},{"key":"1655_CR14","doi-asserted-by":"publisher","DOI":"10.7759\/CUREUS.41633","author":"RL Fernandes","year":"2023","unstructured":"Fernandes\u00a0RL, Ornelas\u00a0MF, Henriques\u00a0AC et\u00a0al (2023) Eosinophilic variant of granulomatosis with polyangiitis. Cureus. https:\/\/doi.org\/10.7759\/CUREUS.41633","journal-title":"Cureus"},{"key":"1655_CR15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/J.ARBRES.2011.11.002","volume":"48","author":"JJ Fibla","year":"2012","unstructured":"Fibla\u00a0JJ, Molins\u00a0L, Blanco\u00a0A et\u00a0al (2012) Video-assisted thoracoscopic lung biopsy in the diagnosis of interstitial lung disease: a\u00a0prospective, multi-center study in 224 patients. Arch Bronconeumol 48:81\u201385. https:\/\/doi.org\/10.1016\/J.ARBRES.2011.11.002","journal-title":"Arch Bronconeumol"},{"key":"1655_CR16","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1136\/ard.2010.137778","volume":"70","author":"O Flossmann","year":"2011","unstructured":"Flossmann\u00a0O, Berden\u00a0A, de Groot\u00a0K et\u00a0al (2011) Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis 70:488\u2013494. https:\/\/doi.org\/10.1136\/ard.2010.137778","journal-title":"Ann Rheum Dis"},{"key":"1655_CR17","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1001\/JAMA.2021.6615","volume":"325","author":"S Furuta","year":"2021","unstructured":"Furuta\u00a0S, Nakagomi\u00a0D, Kobayashi\u00a0Y et\u00a0al (2021) Effect of reduced-dose vs high-dose glucocorticoids added to rituximab on remission induction in ANCA-associated vasculitis: a\u00a0randomized clinical trial. JAMA 325:2178\u20132187. https:\/\/doi.org\/10.1001\/JAMA.2021.6615","journal-title":"JAMA"},{"key":"1655_CR18","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1002\/ART.39637","volume":"68","author":"LA Fussner","year":"2016","unstructured":"Fussner\u00a0LA, Hummel\u00a0AM, Schroeder\u00a0DR et\u00a0al (2016) Factors determining the clinical utility of serial measurements of antineutrophil cytoplasmic antibodies targeting proteinase 3. Arthritis Rheumatol 68:1700\u20131710. https:\/\/doi.org\/10.1002\/ART.39637","journal-title":"Arthritis Rheumatol"},{"key":"1655_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/ANNRHEUMDIS-2021-221794","author":"PC Grayson","year":"2022","unstructured":"Grayson\u00a0PC, Ponte\u00a0C, Suppiah\u00a0R et\u00a0al (2022) 2022 American college of rheumatology\/European alliance of associations for rheumatology classification criteria for eosinophilic granulomatosis with polyangiitis. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/ANNRHEUMDIS-2021-221794","journal-title":"Ann Rheum Dis"},{"key":"1655_CR20","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1002\/ART.21142","volume":"52","author":"K De Groot","year":"2005","unstructured":"De Groot\u00a0K, Rasmussen\u00a0N, Bacon\u00a0PA et\u00a0al (2005) Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 52:2461\u20132469. https:\/\/doi.org\/10.1002\/ART.21142","journal-title":"Arthritis Rheum"},{"key":"1655_CR21","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1056\/NEJMoa1404231","volume":"371","author":"L Guillevin","year":"2014","unstructured":"Guillevin\u00a0L, Pagnoux\u00a0C, Karras\u00a0A et\u00a0al (2014) Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. N\u00a0Engl J Med 371:1771\u20131780. https:\/\/doi.org\/10.1056\/NEJMoa1404231","journal-title":"N Engl J Med"},{"key":"1655_CR22","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1046\/J.1523-1755.1998.00807.X","volume":"53","author":"EC Hagen","year":"1998","unstructured":"Hagen\u00a0EC, Daha\u00a0MR, Hermans\u00a0J et\u00a0al (1998) Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC\/BCR project for ANCA assay standardization. Kidney Int 53:743\u2013753. https:\/\/doi.org\/10.1046\/J.1523-1755.1998.00807.X","journal-title":"Kidney Int"},{"key":"1655_CR23","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1111\/nep.13157","volume":"23","author":"J Hasegawa","year":"2018","unstructured":"Hasegawa\u00a0J, Hoshino\u00a0J, Sekine\u00a0A et\u00a0al (2018) Clinical and pathological features of anti-neutrophil cytoplasmic antibody-associated vasculitis in patients with minor urinary abnormalities. Nephrology 23:1007\u20131012. https:\/\/doi.org\/10.1111\/nep.13157","journal-title":"Nephrology"},{"key":"1655_CR24","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1136\/ARD.2006.062711","volume":"66","author":"B Hellmich","year":"2007","unstructured":"Hellmich\u00a0B, Flossmann\u00a0O, Gross\u00a0WL et\u00a0al (2007) EULAR recommendations for conducting clinical studies and\/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis 66:605\u2013617. https:\/\/doi.org\/10.1136\/ARD.2006.062711","journal-title":"Ann Rheum Dis"},{"key":"1655_CR25","doi-asserted-by":"publisher","first-page":"4868","DOI":"10.1093\/RHEUMATOLOGY\/KEAA924","volume":"60","author":"B Hellmich","year":"2021","unstructured":"Hellmich\u00a0B, Lamprecht\u00a0P, Spearpoint\u00a0P et\u00a0al (2021) New insights into the epidemiology of ANCA-associated vasculitides in Germany: results from a\u00a0claims data study. Rheumatology 60:4868\u20134873. https:\/\/doi.org\/10.1093\/RHEUMATOLOGY\/KEAA924","journal-title":"Rheumatology"},{"key":"1655_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/ard-2022-223764","volume":"0","author":"B Hellmich","year":"2023","unstructured":"Hellmich\u00a0B, Sanchez-Alamo\u00a0B, Schirmer\u00a0JH et\u00a0al (2023) EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update. Ann Rheum Dis 0:1\u201318. https:\/\/doi.org\/10.1136\/ard-2022-223764","journal-title":"Ann Rheum Dis"},{"key":"1655_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223764","author":"B Hellmich","year":"2023","unstructured":"Hellmich\u00a0B, Sanchez-Alamo\u00a0B, Schirmer\u00a0JH et\u00a0al (2023) EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/ard-2022-223764","journal-title":"Ann Rheum Dis"},{"key":"1655_CR28","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/RHEUMATOLOGY\/KET440","volume":"53","author":"K Herlyn","year":"2014","unstructured":"Herlyn\u00a0K, Buckert\u00a0F, Gross\u00a0WL, Reinhold-Keller\u00a0E (2014) Doubled prevalence rates of ANCA-associated vasculitides and giant cell arteritis between 1994 and 2006 in northern Germany. Rheumatology 53:882\u2013889. https:\/\/doi.org\/10.1093\/RHEUMATOLOGY\/KET440","journal-title":"Rheumatology"},{"key":"1655_CR29","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1681\/ASN.2007010090","volume":"18","author":"DRW Jayne","year":"2007","unstructured":"Jayne\u00a0DRW, Gaskin\u00a0G, Rasmussen\u00a0N et\u00a0al (2007) Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J\u00a0Am Soc Nephrol 18:2180\u20132188. https:\/\/doi.org\/10.1681\/ASN.2007010090","journal-title":"J Am Soc Nephrol"},{"key":"1655_CR30","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/nejmoa2023386","volume":"384","author":"DRW Jayne","year":"2021","unstructured":"Jayne\u00a0DRW, Merkel\u00a0PA, Schall\u00a0TJ, Bekker\u00a0P (2021) Avacopan for the treatment of ANCA-associated vasculitis. N\u00a0Engl J Med 384:599\u2013609. https:\/\/doi.org\/10.1056\/nejmoa2023386","journal-title":"N Engl J Med"},{"key":"1655_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ART.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette\u00a0JC, Falk\u00a0RJ, Bacon\u00a0PA et\u00a0al (2013) 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65:1\u201311. https:\/\/doi.org\/10.1002\/ART.37715","journal-title":"Arthritis Rheum"},{"key":"1655_CR32","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1136\/annrheumdis-2018-214245","volume":"78","author":"RB Jones","year":"2019","unstructured":"Jones\u00a0RB, Hiemstra\u00a0TF, Ballarin\u00a0J et\u00a0al (2019) Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a\u00a0randomised, non-inferiority trial. Ann Rheum Dis 78:399\u2013405. https:\/\/doi.org\/10.1136\/annrheumdis-2018-214245","journal-title":"Ann Rheum Dis"},{"key":"1655_CR33","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMoa0909169","volume":"363","author":"RB Jones","year":"2010","unstructured":"Jones\u00a0RB, Tervaert\u00a0JWC, Hauser\u00a0T et\u00a0al (2010) Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N\u00a0Engl J Med 363:211\u2013220. https:\/\/doi.org\/10.1056\/NEJMoa0909169","journal-title":"N Engl J Med"},{"key":"1655_CR34","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1093\/rheumatology\/keac423","volume":"62","author":"A Kronbichler","year":"2023","unstructured":"Kronbichler\u00a0A, Bond\u00a0M, Dejacco\u00a0C (2023) Classification criteria for ANCA-associated vasculitis: one size does not fit all! Baillieres Clin Rheumatol 62:993\u2013995. https:\/\/doi.org\/10.1093\/rheumatology\/keac423","journal-title":"Baillieres Clin Rheumatol"},{"key":"1655_CR35","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.kint.2018.10.001","volume":"94","author":"A Kronbichler","year":"2018","unstructured":"Kronbichler\u00a0A, Jayne\u00a0DRW (2018) ANCA renal risk score: is prediction of end-stage renal disease at baseline possible? Kidney Int 94:1045\u20131047. https:\/\/doi.org\/10.1016\/j.kint.2018.10.001","journal-title":"Kidney Int"},{"key":"1655_CR36","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.21037\/JTD-20-2431","volume":"13","author":"S Kronborg-White","year":"2021","unstructured":"Kronborg-White\u00a0S, Sritharan\u00a0SS, Madsen\u00a0LB et\u00a0al (2021) Integration of cryobiopsies for interstitial lung disease diagnosis is a\u00a0valid and safe diagnostic strategy-experiences based on 250 biopsy procedures. J\u00a0Thorac Dis 13:1455\u20131465. https:\/\/doi.org\/10.21037\/JTD-20-2431","journal-title":"J Thorac Dis"},{"key":"1655_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/JCM12175721","author":"Y Kushima","year":"2023","unstructured":"Kushima\u00a0Y, Shimizu\u00a0Y, Hoshi\u00a0H et\u00a0al (2023) Changes in peripheral blood eosinophil counts and risk of eosinophilic granulomatosis with polyangiitis onset after initiation of dupilumab administration in adult patients with asthma. J\u00a0Clin Med. https:\/\/doi.org\/10.3390\/JCM12175721","journal-title":"J Clin Med"},{"key":"1655_CR38","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.7326\/0003-4819-134-11-200106050-00009","volume":"134","author":"JB Levy","year":"2001","unstructured":"Levy\u00a0JB, Turner\u00a0AN, Rees\u00a0AJ, Pusey\u00a0CD (2001) Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med 134:1033\u20131042. https:\/\/doi.org\/10.7326\/0003-4819-134-11-200106050-00009","journal-title":"Ann Intern Med"},{"key":"1655_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12515-9","author":"PA Lyons","year":"2019","unstructured":"Lyons\u00a0PA, Peters\u00a0JE, Alberici\u00a0F et\u00a0al (2019) Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-019-12515-9","journal-title":"Nat Commun"},{"key":"1655_CR40","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1056\/NEJMoa1108735","volume":"367","author":"PA Lyons","year":"2012","unstructured":"Lyons\u00a0PA, Rayner\u00a0TF, Trivedi\u00a0S et\u00a0al (2012) Genetically distinct subsets within ANCA-associated vasculitis europe PMC funders group. N\u00a0Engl J Med 367:214\u2013223. https:\/\/doi.org\/10.1056\/NEJMoa1108735","journal-title":"N Engl J Med"},{"key":"1655_CR41","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead199","author":"A Maunz","year":"2023","unstructured":"Maunz\u00a0A, Jacoby\u00a0J, Henes\u00a0J et\u00a0al (2023) Association of the AAV-PRO questionnaire with established outcome measures in AAV. Rheumatology. https:\/\/doi.org\/10.1093\/rheumatology\/kead199","journal-title":"Rheumatology"},{"key":"1655_CR42","doi-asserted-by":"publisher","first-page":"i80","DOI":"10.1093\/ndt\/gfw361","volume":"32","author":"SP McAdoo","year":"2017","unstructured":"McAdoo\u00a0SP, Pusey\u00a0CD (2017) Is there a\u00a0role for TNFa\u03b1 blockade in ANCA-associated vasculitis and glomerulonephritis? Nephrol Dial Transplant 32:i80\u2013i88. https:\/\/doi.org\/10.1093\/ndt\/gfw361","journal-title":"Nephrol Dial Transplant"},{"key":"1655_CR43","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/J.KINT.2017.03.014","volume":"92","author":"SP McAdoo","year":"2017","unstructured":"McAdoo\u00a0SP, Tanna\u00a0A, Hru\u0161kov\u00e1\u00a0Z et\u00a0al (2017) Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients. Kidney Int 92:693\u2013702. https:\/\/doi.org\/10.1016\/J.KINT.2017.03.014","journal-title":"Kidney Int"},{"key":"1655_CR44","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1136\/annrheumdis-2016-210002","volume":"76","author":"EM Miloslavsky","year":"2017","unstructured":"Miloslavsky\u00a0EM, Naden\u00a0RP, Bijlsma\u00a0JWJ et\u00a0al (2017) Development of a\u00a0glucocorticoid toxicity index (GTI) using multicriteria decision analysis. Ann Rheum Dis 76:543\u2013546. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210002","journal-title":"Ann Rheum Dis"},{"key":"1655_CR45","doi-asserted-by":"publisher","DOI":"10.1136\/ARD-2023-224756","author":"B Molina","year":"2023","unstructured":"Molina\u00a0B, Padoan\u00a0R, Urban\u00a0ML et\u00a0al (2023) Dupilumab for relapsing or refractory sinonasal and\/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a\u00a0European retrospective study. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/ARD-2023-224756","journal-title":"Ann Rheum Dis"},{"key":"1655_CR46","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez038","author":"RJ Pepper","year":"2019","unstructured":"Pepper\u00a0RJ, McAdoo\u00a0SP, Moran\u00a0SM et\u00a0al (2019) A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody\u2013associated vasculitis. Rheumatology. https:\/\/doi.org\/10.1093\/rheumatology\/kez038","journal-title":"Rheumatology"},{"key":"1655_CR47","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.2215\/CJN.04710420","volume":"15","author":"ED Poggio","year":"2017","unstructured":"Poggio\u00a0ED, Mcclelland\u00a0RL, Blank\u00a0KN et\u00a0al (2017) Systematic review and meta-analysis of native kidney biopsy complications. Clin J Am Soc Nephrol 15:1595\u20131602. https:\/\/doi.org\/10.2215\/CJN.04710420","journal-title":"Clin J Am Soc Nephrol"},{"key":"1655_CR48","doi-asserted-by":"publisher","first-page":"E2243799","DOI":"10.1001\/JAMANETWORKOPEN.2022.43799","volume":"5","author":"X Pu\u00e9chal","year":"2022","unstructured":"Pu\u00e9chal\u00a0X, Iudici\u00a0M, Perrodeau\u00a0E et\u00a0al (2022) Rituximab vs cyclophosphamide induction therapy for patients with granulomatosis with polyangiitis. JAMA Netw Open 5:E2243799. https:\/\/doi.org\/10.1001\/JAMANETWORKOPEN.2022.43799","journal-title":"JAMA Netw Open"},{"key":"1655_CR49","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1002\/ART.40205","volume":"69","author":"X Pu\u00e9chal","year":"2017","unstructured":"Pu\u00e9chal\u00a0X, Pagnoux\u00a0C, Baron\u00a0G et\u00a0al (2017) Adding azathioprine to remission-induction glucocorticoids for eosinophilic granulomatosis with polyangiitis (Churg-Strauss), microscopic polyangiitis, or polyarteritis nodosa without poor prognosis factors: a\u00a0randomized, controlled trial. Arthritis Rheumatol 69:2175\u20132186. https:\/\/doi.org\/10.1002\/ART.40205","journal-title":"Arthritis Rheumatol"},{"key":"1655_CR50","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1093\/rheumatology\/keac267","volume":"62","author":"YJ Pyo","year":"2023","unstructured":"Pyo\u00a0YJ, Ahn\u00a0SS, Song\u00a0JJ et\u00a0al (2023) Reclassification of previously diagnosed GPA patients using the 2022 ACR\/EULAR classification criteria. Baillieres Clin Rheumatol 62:1179\u20131186. https:\/\/doi.org\/10.1093\/rheumatology\/keac267","journal-title":"Baillieres Clin Rheumatol"},{"key":"1655_CR51","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1136\/annrheumdis-2017-212713","volume":"77","author":"J Robson","year":"2018","unstructured":"Robson\u00a0J, Dawson\u00a0J, Cronholm\u00a0PF et\u00a0al (2018) Validation of the ANCA-associated vasculitis patient-reported outcomes (AAV-PRO) questionnarie. Ann Rheum Dis 77:1157\u20131164. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212713","journal-title":"Ann Rheum Dis"},{"key":"1655_CR52","doi-asserted-by":"publisher","DOI":"10.1136\/ANNRHEUMDIS-2021-221795","author":"JC Robson","year":"2022","unstructured":"Robson\u00a0JC, Grayson\u00a0PC, Ponte\u00a0C et\u00a0al (2022) 2022 American college of rheumatology\/European alliance of associations for rheumatology classification criteria for granulomatosis with polyangiitis. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/ANNRHEUMDIS-2021-221795","journal-title":"Ann Rheum Dis"},{"key":"1655_CR53","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.3899\/JRHEUM.161139","volume":"44","author":"JC Robson","year":"2017","unstructured":"Robson\u00a0JC, Tomasson\u00a0G, Milman\u00a0N et\u00a0al (2017) OMERACT endorsement of patient-reported outcome instruments in antineutrophil cytoplasmic antibody-associated vasculitis. J\u00a0Rheumatol 44:1529\u20131535. https:\/\/doi.org\/10.3899\/JRHEUM.161139","journal-title":"J Rheumatol"},{"key":"1655_CR54","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/J.KINT.2021.05.015","volume":"100","author":"BH Rovin","year":"2021","unstructured":"Rovin\u00a0BH, Adler\u00a0SG, Barratt\u00a0J et\u00a0al (2021) Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases. Kidney Int 100:753\u2013779. https:\/\/doi.org\/10.1016\/J.KINT.2021.05.015","journal-title":"Kidney Int"},{"key":"1655_CR55","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1002\/ART.39786","volume":"68","author":"JH Schirmer","year":"2016","unstructured":"Schirmer\u00a0JH, Wright\u00a0MN, Herrmann\u00a0K et\u00a0al (2016) Myeloperoxidase-antineutrophil cytoplasmic antibody (ANCA)-positive granulomatosis with polyangiitis (Wegener\u2019s) is a\u00a0clinically distinct subset of ANCA-associated vasculitis: a\u00a0retrospective analysis of 315 patients from a\u00a0German vasculitis referral center. Arthritis Rheumatol 68:2953\u20132963. https:\/\/doi.org\/10.1002\/ART.39786","journal-title":"Arthritis Rheumatol"},{"key":"1655_CR56","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1183\/09031936.97.10122738","volume":"10","author":"A Schnabel","year":"1997","unstructured":"Schnabel\u00a0A, Holl-Ulrich\u00a0K, Dalhoff\u00a0K et\u00a0al (1997) Efficacy of transbronchial biopsy in pulmonary vaculitides. Eur Respir\u00a0J 10:2738\u20132743. https:\/\/doi.org\/10.1183\/09031936.97.10122738","journal-title":"Eur Respir J"},{"key":"1655_CR57","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1136\/ANNRHEUMDIS-2019-216863","volume":"79","author":"RM Smith","year":"2020","unstructured":"Smith\u00a0RM, Jones\u00a0RB, Specks\u00a0U et\u00a0al (2020) Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis. Ann Rheum Dis 79:1243\u20131249. https:\/\/doi.org\/10.1136\/ANNRHEUMDIS-2019-216863","journal-title":"Ann Rheum Dis"},{"key":"1655_CR58","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1136\/ARD-2022-223559","volume":"82","author":"RM Smith","year":"2023","unstructured":"Smith\u00a0RM, Jones\u00a0RB, Specks\u00a0U et\u00a0al (2023) Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial. Ann Rheum Dis 82:937\u2013944. https:\/\/doi.org\/10.1136\/ARD-2022-223559","journal-title":"Ann Rheum Dis"},{"key":"1655_CR59","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00393-021-01055-7","volume":"80","author":"C Specker","year":"2021","unstructured":"Specker\u00a0C, Aries\u00a0P, Braun\u00a0J et\u00a0al (2021) Empfehlungen und Stellungnahmen von Fachgesellschaften Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2\/COVID-19 pandemic, including recommendations for COVID-19 vaccination Supplementary Information Core recommendations. Z\u00a0Rheumatol 80:33\u201348. https:\/\/doi.org\/10.1007\/s00393-021-01055-7","journal-title":"Z Rheumatol"},{"key":"1655_CR60","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMOA1213277\/SUPPL_FILE\/NEJMOA1213277_DISCLOSURES.PDF","volume":"369","author":"U Specks","year":"2013","unstructured":"Specks\u00a0U, Merkel\u00a0PA, Seo\u00a0P et\u00a0al (2013) Efficacy of remission-induction regimens for ANCA-associated vasculitis. N\u00a0Engl J Med 369:417\u2013427. https:\/\/doi.org\/10.1056\/NEJMOA1213277\/SUPPL_FILE\/NEJMOA1213277_DISCLOSURES.PDF","journal-title":"N Engl J Med"},{"key":"1655_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2022.152010","author":"JH Stone","year":"2022","unstructured":"Stone\u00a0JH, McDowell\u00a0PJ, Jayne\u00a0DRW et\u00a0al (2022) The glucocorticoid toxicity index: measuring change in glucocorticoid toxicity over time. Semin Arthritis Rheum. https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152010","journal-title":"Semin Arthritis Rheum"},{"key":"1655_CR62","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa0909905","volume":"363","author":"JH Stone","year":"2010","unstructured":"Stone\u00a0JH, Merkel\u00a0PA, Spiera\u00a0R et\u00a0al (2010) Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N\u00a0Engl J Med 363:221\u2013232. https:\/\/doi.org\/10.1056\/NEJMoa0909905","journal-title":"N Engl J Med"},{"key":"1655_CR63","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1136\/annrheumdis-2020-219498","volume":"80","author":"A Strangfeld","year":"2021","unstructured":"Strangfeld\u00a0A, Sch\u00e4fer\u00a0M, Gianfrancesco\u00a0MA et\u00a0al (2021) Factors associated with COVID-19- related death in people with rheumatic diseases: results from the COVID-19 Global. Ann Rheum Dis 80:930\u2013942. https:\/\/doi.org\/10.1136\/annrheumdis-2020-219498","journal-title":"Ann Rheum Dis"},{"key":"1655_CR64","doi-asserted-by":"publisher","DOI":"10.1136\/ANNRHEUMDIS-2021-221796","author":"R Suppiah","year":"2022","unstructured":"Suppiah\u00a0R, Robson\u00a0JC, Grayson\u00a0PC et\u00a0al (2022) 2022 American college of rheumatology\/European alliance of associations for rheumatology classification criteria for microscopic polyangiitis. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/ANNRHEUMDIS-2021-221796","journal-title":"Ann Rheum Dis"},{"key":"1655_CR65","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/00000478-199104000-00001","volume":"15","author":"WD Travis","year":"1991","unstructured":"Travis\u00a0WD, Hoffman\u00a0GS, Leavitt\u00a0RY et\u00a0al (1991) Pulmonary GPA histology. Am J Surg Pathol 15:315\u2013333","journal-title":"Am J Surg Pathol"},{"key":"1655_CR66","doi-asserted-by":"publisher","first-page":"00141","DOI":"10.1183\/23120541.00141-2023","volume":"9","author":"T Villeneuve","year":"2023","unstructured":"Villeneuve\u00a0T, Pr\u00e9vot\u00a0G, Pugnet\u00a0G et\u00a0al (2023) Role of bronchoscopy for respiratory involvement in granulomatosis with polyangiitis and microscopic polyangiitis. ERJ Open Res 9:141\u20132023. https:\/\/doi.org\/10.1183\/23120541.00141-2023","journal-title":"ERJ Open Res"},{"key":"1655_CR67","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/ki.2013.131","volume":"84","author":"M Walsh","year":"2013","unstructured":"Walsh\u00a0M, Casian\u00a0A, Flossmann\u00a0O et\u00a0al (2013) Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear. Kidney Int 84:397\u2013402. https:\/\/doi.org\/10.1038\/ki.2013.131","journal-title":"Kidney Int"},{"key":"1655_CR68","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1053\/j.ajkd.2010.10.049","volume":"57","author":"M Walsh","year":"2011","unstructured":"Walsh\u00a0M, Catapano\u00a0F, Szpirt\u00a0W et\u00a0al (2011) Plasma exchange for renal vasculitis and idiopathic rapidly progressive glomerulonephritis: a\u00a0meta-analysis. Am J Kidney Dis 57:566\u2013574. https:\/\/doi.org\/10.1053\/j.ajkd.2010.10.049","journal-title":"Am J Kidney Dis"},{"key":"1655_CR69","doi-asserted-by":"publisher","DOI":"10.1136\/BMJ-2021-064604","author":"M Walsh","year":"2022","unstructured":"Walsh\u00a0M, Collister\u00a0D, Zeng\u00a0L et\u00a0al (2022) The effects of plasma exchange in patients with ANCA-associated vasculitis: an updated systematic review and meta-analysis. BMJ. https:\/\/doi.org\/10.1136\/BMJ-2021-064604","journal-title":"BMJ"},{"key":"1655_CR70","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1056\/NEJMoa1803537","volume":"382","author":"M Walsh","year":"2020","unstructured":"Walsh\u00a0M, Merkel\u00a0P, Peh\u00a0CA et\u00a0al (2020) Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis. N\u00a0Engl J Med 382:622\u2013631. https:\/\/doi.org\/10.1056\/NEJMoa1803537","journal-title":"N Engl J Med"},{"key":"1655_CR71","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1056\/NEJMoa1702079","volume":"376","author":"ME Wechsler","year":"2017","unstructured":"Wechsler\u00a0ME, Akuthota\u00a0P, Jayne\u00a0D et\u00a0al (2017) Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis. N\u00a0Engl J Med 376:1921\u20131932. https:\/\/doi.org\/10.1056\/NEJMoa1702079","journal-title":"N Engl J Med"},{"key":"1655_CR72","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/S0046-8177(88)80174-6","volume":"19","author":"SA Yousem","year":"1988","unstructured":"Yousem\u00a0SA, Lombard\u00a0CM (1988) The eosinophilic variant of Wegener\u2019s granulomatosis. Hum Pathol 19:682\u2013688. https:\/\/doi.org\/10.1016\/S0046-8177(88)80174-6","journal-title":"Hum Pathol"},{"key":"1655_CR73","unstructured":"ACR Meeting Abstracts Rituximab versus conventional therapeutic strategy for remission induction in eosinophilic granulomatosis with polyangiitis: a\u00a0double-blind, randomized, controlled trial. https:\/\/acrabstracts.org\/abstract\/rituximab-versus-conventional-therapeutic-strategy-for-remission-induction-in-eosinophilic-granulomatosis-with-polyangiitis-a-double-blind-randomized-controlled-trial\/. Zugegriffen: 22. Sept. 2023"},{"key":"1655_CR74","unstructured":"https:\/\/www.g-ba.de\/downloads\/40-268-8727\/2022-08-04_AM-RL-XII_Avacopan_D-778_TrG.pdf"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-023-01655-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-023-01655-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-023-01655-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T12:03:36Z","timestamp":1706702616000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-023-01655-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,22]]},"references-count":74,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["1655"],"URL":"https:\/\/doi.org\/10.1007\/s00108-023-01655-2","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"value":"2731-7080","type":"print"},{"value":"2731-7099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,22]]},"assertion":[{"value":"18 December 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"C.\u00a0L\u00f6ffler und B.\u00a0Hellmich geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}